meglumine and Fibrocystic Breast Disease

meglumine has been researched along with Fibrocystic Breast Disease in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bulan, O; Clymer, BD; Heverhagen, JT; Knopp, MV; Kurc, T; Orsdemir, A; Stevens, R; Woods, BJ1
Beck, R; Haustein, J; Heywang-Köbrunner, SH; Lommatzsch, B; Nathrath, WB; Pohl, C; Untch, M1
Fischer, U; Grabbe, E; Kahlen, O; Kopka, L; Vosshenrich, R1
Evans, WP; Flamig, DP; Griffey, RH; Hagans, JE; Harms, SE; Pierce, WB1

Other Studies

4 other study(ies) available for meglumine and Fibrocystic Breast Disease

ArticleYear
Malignant-lesion segmentation using 4D co-occurrence texture analysis applied to dynamic contrast-enhanced magnetic resonance breast image data.
    Journal of magnetic resonance imaging : JMRI, 2007, Volume: 25, Issue:3

    Topics: Biopsy; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Contrast Media; Diagnosis, Differential; Female; Fibrocystic Breast Disease; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Meglumine; Neural Networks, Computer; Observer Variation; Organometallic Compounds; Retrospective Studies; ROC Curve; Sensitivity and Specificity

2007
Contrast-enhanced MR imaging of the breast: comparison of two different doses of gadopentetate dimeglumine.
    Radiology, 1994, Volume: 191, Issue:3

    Topics: Breast; Breast Diseases; Breast Neoplasms; Carcinoma; Contrast Media; Drug Combinations; Female; Fibroadenoma; Fibrocystic Breast Disease; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pentetic Acid

1994
[Contrast medium assisted dynamic MR-mammography after diagnostic and therapeutic interventions on the breast].
    Bildgebung = Imaging, 1996, Volume: 63, Issue:2

    Topics: Biopsy; Breast; Breast Neoplasms; Combined Modality Therapy; Contrast Media; Drug Combinations; Female; Fibrocystic Breast Disease; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Mastectomy, Segmental; Meglumine; Organometallic Compounds; Pentetic Acid; Postoperative Complications; Radiotherapy, Adjuvant; Retrospective Studies

1996
Three-dimensional gadolinium-enhanced MR imaging of the breast: pulse sequence with fat suppression and magnetization transfer contrast. Work in progress.
    Radiology, 1991, Volume: 181, Issue:3

    Topics: Adult; Aged; Breast; Breast Diseases; Breast Neoplasms; Contrast Media; Drug Combinations; Fat Necrosis; Female; Fibrocystic Breast Disease; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid

1991